-copan
Drugs that block complement, part of the innate immune system.
- Drugs ending in -copan: 5
- Approved somewhere: 3
- With a US drug page: 3
- Stem
- -copan
- Class
- Drugs that block complement, part of the innate immune system
- Most common targets
- C5AR1 (1), CFD (1), CFB (1), LTB4R, LTB4R2 (1), C5 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -copan, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Avacopan | Approved | C5AR1 | C5a anaphylatoxin chemotactic receptor antagonist |
| Danicopan | Approved | CFD | Complement factor D inhibitor |
| Iptacopan | Approved | CFB | Complement factor B inhibitor |
| Nomacopan | Phase 3 | LTB4R, LTB4R2, C5 | Leukotriene B4 receptor inhibitor |
| Vemircopan | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO